§ 13F · FUND PROFILE
Elmind Capital, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 34Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$338.9T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | 1.17M | $41.6T | 12.3% | NEW |
| 2 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.85M | $39.0T | 11.5% | NEW |
| 3 | VRDN | VIRIDIAN THERAPEUTICS INC | 859K | $26.7T | 7.9% | NEW |
| 4 | VERA | VERA THERAPEUTICS INC | 483K | $24.4T | 7.2% | NEW |
| 5 | CLDX | CELLDEX THERAPEUTICS INC NEW | 865K | $23.5T | 6.9% | NEW |
| 6 | CGON | CG ONCOLOGY INC | 493K | $20.4T | 6.0% | NEW |
| 7 | BCRX | BIOCRYST PHARMACEUTICALS INC | 2.15M | $16.8T | 4.9% | NEW |
| 8 | PCVX | VAXCYTE INC | 292K | $13.4T | 4.0% | NEW |
| 9 | BEAM | BEAM THERAPEUTICS INC | 476K | $13.2T | 3.9% | NEW |
| 10 | PHVS | PHARVARIS N V | 476K | $13.2T | 3.9% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ELMIND SIGNAL
AC read
Elmind Capital, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed